Shotaro Shimada

Hatanodai, 1428666, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Comparison between Pola-R-CHP and R-CHOP regimens in patients newly diagnosed with diffuse large B-cell lymphoma: a propensity score-matched study.

Comparison between Pola-R-CHP and R-CHOP regimens in patients newly diagnosed with diffuse large B-cell lymphoma: a propensity score-matched study.

Journal: Scientific reports

Published: January 29, 2026

Anatomical patterns at first confirmed relapse or refractory disease predict outcomes in diffuse large B-cell lymphoma.

Anatomical patterns at first confirmed relapse or refractory disease predict outcomes in diffuse large B-cell lymphoma.

Journal: International journal of hematology

Published: September 16, 2025

Donor IL-10 and FOXP3 single-nucleotide polymorphisms associated with post-transplantation outcomes.

Donor IL-10 and FOXP3 single-nucleotide polymorphisms associated with post-transplantation outcomes.

Journal: Leukemia & lymphoma

Published: August 25, 2025

Acute Promyelocytic Leukemia with double minute chromosomes: a rare case with high relapse risk.

Acute Promyelocytic Leukemia with double minute chromosomes: a rare case with high relapse risk.

Journal: Oxford medical case reports

Published: July 18, 2025

Clinical impact of donor telomere length after umbilical cord blood transplantation.

Clinical impact of donor telomere length after umbilical cord blood transplantation.

Journal: Cytotherapy

Published: December 01, 2024

Disseminated toxoplasmosis confirmed by tachyzoites and cysts in bone marrow smear after cord blood transplantation

Disseminated toxoplasmosis confirmed by tachyzoites and cysts in bone marrow smear after cord blood transplantation

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 06, 2024

High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular Lymphoma.

High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular Lymphoma.

Journal: International journal of molecular sciences

Published: September 22, 2024

Clinicopathological differences in MYC and BCL2 protein expression between primary extranodal and nodal diffuse large B-cell lymphoma.

Clinicopathological differences in MYC and BCL2 protein expression between primary extranodal and nodal diffuse large B-cell lymphoma.

Journal: Pathology, research and practice

Published: April 29, 2024

Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation.

Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation.

Journal: Transplantation proceedings

Published: April 25, 2024

Acquired thrombotic thrombocytopenic purpura during durvalumab monotherapy for non-small cell lung cancer

Acquired thrombotic thrombocytopenic purpura during durvalumab monotherapy for non-small cell lung cancer

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 04, 2024

Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation.

Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation.

Journal: International journal of hematology

Published: September 30, 2023

CD5- and CD10-positive MYC and BCL2 double-expressor diffuse large B-cell lymphoma with MYD88L265P mutation: a case report and literature review

CD5- and CD10-positive MYC and BCL2 double-expressor diffuse large B-cell lymphoma with MYD88L265P mutation: a case report and literature review

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 12, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026